Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

The Lancet confirms effectiveness of AZ/Oxford University’s COVID-19 vaccine

Final average efficacy analysis found to be 70.4%

Lucid Group Evolve and Simplify its Brand Architecture

The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise...

Lucid Group Communications Limited

University spin-out fund makes half a million pound first investments

University partnership Northern Accelerator has made over £500,000 worth of investments into two innovative university spin-out businesses in the health and biotech sectors from its £1.7M Seed Investment Fund

Onyx Health

- PMLiVE

Accord Healthcare’s COVID-19 agility praised at PMEA 2020

Accord Healthcare picks up inaugural Agility Award in Pharma Market Excellence

- PMLiVE

Q&A: Sarah Mikhailov

PME interviews Havas Life Medicom's Managing Partner

- PMLiVE

Why digital is the solution to the healthcare crisis

Amid the uncertainty of the pandemic, rather than halting progress, in many ways the crisis has expedited it

- PMLiVE

Jazz Pharma’s SCLC drug fails to meet primary endpoint in combo trial

Drug combination failed to improve overall survival rate

11 London - Migraine-friendly colours

Migraine-friendly colours for the home

You may not realise it, but colour impacts migraines. 11 London worked with Teva Pharmaceuticals UK, Dulux Paints and the National Migraine Centre to test this theory among 1,200 migraine...

11 London

- PMLiVE

How can virtual pharma companies de-risk new product launches?

The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market

- PMLiVE

Moderna expects to supply 125 million COVID-19 vaccine doses in Q1 2021

85 million to 100 million doses will be available in the US

- PMLiVE

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Three-year collaboration agreement will seek to develop a range of therapeutic candidates

- PMLiVE

NIAID chief back-pedals on criticism of UK’s Pfizer vaccine approval process

Anthony Fauci apologised for previous comments in BBC interview

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links